MOBILE VIEW  | 

NON-CHIRODROPID COELENTERATES

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Coelenterates are marine organisms characterized by a gelatinous body, tentacles, and stinging cells called nematocysts. The non-chirodropid coelenterates do NOT include the Chironex fleckeri and the Chiropsalmus species of jellyfish. These are discussed in a separate management, Chirodropid Coelenterates.

Specific Substances

    A) CUBOZOAN CLASS ("BOX JELLYFISH")
    1) Carybdieds
    2) Coelenterates, non-chirodropid
    HYDROZOAN CLASS
    1) Hydroids
    2) Physalia species
    3) Limnomedusae
    4) Gonionemus species
    SCYPHOZOAN CLASS ("TRUE JELLYFISH")
    1) Cyanea species
    2) Catosylus species
    3) Chrysaora species
    4) Pelagia species
    5) Rhizostoma species
    6) Stomolophus species
    7) Aurelia species
    ANTHOZOA CLASS
    1) Hard and soft corals
    2) Anemones

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) BACKGROUND: This document contains information on stings from coelenterates from the classes hydrozoa (eg Portuguese Man O'War, bluebottle) and scyphozoa (true jellyfish), and some jellyfish from the order caybideidea (jimble, fire jelly). Box jellyfish from the order chirodropidea (Australian box jellyfish, C fleckeri), and those causing Irukandji Syndrome (primarily Carukia barnesi), anemones and corals are covered in separate managements. Coelenterates are marine animals that are widely distributed throughout tropical and temperate waters. Nematocysts that can discharge toxins are present on the tentacles and often the bodies or bells.
    B) TOXICOLOGY: The venoms are complex mixtures containing proteins, polypeptides and enzymes.
    C) EPIDEMIOLOGY: Stings are common, and result in local pain and skin irritation. Fatalities are not well documented, and if they occur are extremely rare. Swimmers, divers, snorkelers and fisherman are at greatest risk. Clinical effects may develop following contact with intact or dismembered animals, or nets containing body parts.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE ENVENOMATION
    a) The most common syndrome is immediate pain followed by an erythematous urticarial eruption. Acute local effects may include pain, skin eruption, exaggerated local angioedema, and papular urticaria that becomes noticeable in 4 to 24 hours postexposure. Pruritus may also develop. Mild systemic effects such as weakness, vertigo, nausea, headache, pain and spasms in large muscle groups, arthralgia, lacrimation, and perspiration have been reported.
    2) SEVERE ENVENOMATION
    a) In very severe stings there may be difficulty breathing and pain on respiration, changes in the pulse rate, and severe muscle spasms. Hemolysis with secondary renal failure is very rare, but has been reported.
    b) True anaphylactic reactions following jellyfish stings are becoming more common.
    c) An "Irukandji syndrome" may occur following jellyfish envenomations which may consist of pain, which may be severe, typically starts in the lower back and may spread to the limbs, abdomen and chest. It may be accompanied by nausea, vomiting, diaphoresis, headache, and sometimes piloerection. Tachycardia, severe hypertension, hyperventilation, headache, restlessness, anxiety, a feeling of impending doom, and palpitations are reported. Hypotension is reported to commonly follow hypertensive crisis. In severe cases, pulmonary edema may develop. This is covered in detail in a separate management (See IRUKANDJI SYNDROME).

Laboratory Monitoring

    A) Monitor vital signs following jellyfish envenomations.
    B) ECG and continuous cardiac monitoring should be performed in patients with signs and symptoms of cardiac dysfunction.

Treatment Overview

    0.4.7) BITES/STINGS
    A) DECONTAMINATION
    1) Tentacles should be removed manually, using a stick or other implement or gloved hands to avoid injury to the rescuer.
    B) HOT WATER
    1) Hot water immersion is recommended for stings by blue bottle and non-tropical jellyfish. Immersion of the affected area in hot water (113 F or 45 C) for up to 20 minutes has been shown to decrease pain and prevent recurrence of pain with blue bottle stings. Immersion is preferred over a hot water shower as it provides a more consistent temperature and contact with the skin.
    C) ACETIC ACID
    1) Vinegar is recommended for stings by box jellyfish and related chirodropid jellyfish, jellyfish causing irukandji syndrome, and for stings by unknown tropical marina animals. For all cubozoan ("box jellyfish") stings, apply vinegar (4% to 6% acetic acid) for 30 minutes. Vinegar may irritate the stings, but should still be applied because it inhibits unfired nematocysts. The remaining nematocysts must be removed manually.
    D) LIDOCAINE
    1) Topical lidocaine decreases pain and may decrease nematocyst discharge from Chrysaora quinquecirrha (sea nettle) Chiropsalmus quadrumanus (sea wasp) and Physalia physalis (Portuguese man-of-war).
    E) MILD TO MODERATE ENVENOMATION
    1) Use ice packs, topical anesthetics, acetaminophen and NSAIDs to control pain. Topical corticosteroids and topical or oral antihistamines may be used for pruritic dermal reactions.
    F) SEVERE ENVENOMATION
    1) Treat hemolysis with IV fluids to maintain urine output and red blood cell transfusion as needed. Treat hypotension with IV fluids, add vasopressors, if hypotension persists.
    G) ALLERGIC REACTION
    1) MILD/MODERATE: Antihistamines with or without inhaled beta agonists, corticosteroids or epinephrine. SEVERE: Oxygen, aggressive airway management, antihistamines, epinephrine, corticosteroids, ECG monitoring, and IV fluids.
    H) PATIENT DISPOSITION
    1) HOME CRITERIA: Most patients can be managed at home with dermal decontamination, and home or over-the-counter treatments for pain and pruritus.
    2) OBSERVATION CRITERIA: Patients with severe pain or systemic manifestations should be referred to a healthcare facility.
    3) ADMISSION CRITERIA: Patients with intractable pain or severe systemic manifestations should be admitted.
    4) CONSULT CRITERIA: Consult a medical toxicologist or poison center for patients with severe symptoms or in whom the diagnosis is unclear.
    I) TOXICOKINETICS
    1) Onset of pain is rapid, rash may appear within the first few hours and requires several days to resolve.
    J) PITFALLS
    1) A variety of methods have been recommended to treat pain and/or prevent nematocyst discharge (topical ethanol, meat tenderizer, ammonia, papain, baking soda) though evidence suggests that many of these methods are not effective.
    K) DIFFERENTIAL DIAGNOSIS
    1) Stings from other jellyfish, anemones, coral, or fish. Chemical burn.

Range Of Toxicity

    A) TOXICITY: Fatalities are not well documented and if they do occur they are extremely rare.

Summary Of Exposure

    A) BACKGROUND: This document contains information on stings from coelenterates from the classes hydrozoa (eg Portuguese Man O'War, bluebottle) and scyphozoa (true jellyfish), and some jellyfish from the order caybideidea (jimble, fire jelly). Box jellyfish from the order chirodropidea (Australian box jellyfish, C fleckeri), and those causing Irukandji Syndrome (primarily Carukia barnesi), anemones and corals are covered in separate managements. Coelenterates are marine animals that are widely distributed throughout tropical and temperate waters. Nematocysts that can discharge toxins are present on the tentacles and often the bodies or bells.
    B) TOXICOLOGY: The venoms are complex mixtures containing proteins, polypeptides and enzymes.
    C) EPIDEMIOLOGY: Stings are common, and result in local pain and skin irritation. Fatalities are not well documented, and if they occur are extremely rare. Swimmers, divers, snorkelers and fisherman are at greatest risk. Clinical effects may develop following contact with intact or dismembered animals, or nets containing body parts.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE ENVENOMATION
    a) The most common syndrome is immediate pain followed by an erythematous urticarial eruption. Acute local effects may include pain, skin eruption, exaggerated local angioedema, and papular urticaria that becomes noticeable in 4 to 24 hours postexposure. Pruritus may also develop. Mild systemic effects such as weakness, vertigo, nausea, headache, pain and spasms in large muscle groups, arthralgia, lacrimation, and perspiration have been reported.
    2) SEVERE ENVENOMATION
    a) In very severe stings there may be difficulty breathing and pain on respiration, changes in the pulse rate, and severe muscle spasms. Hemolysis with secondary renal failure is very rare, but has been reported.
    b) True anaphylactic reactions following jellyfish stings are becoming more common.
    c) An "Irukandji syndrome" may occur following jellyfish envenomations which may consist of pain, which may be severe, typically starts in the lower back and may spread to the limbs, abdomen and chest. It may be accompanied by nausea, vomiting, diaphoresis, headache, and sometimes piloerection. Tachycardia, severe hypertension, hyperventilation, headache, restlessness, anxiety, a feeling of impending doom, and palpitations are reported. Hypotension is reported to commonly follow hypertensive crisis. In severe cases, pulmonary edema may develop. This is covered in detail in a separate management (See IRUKANDJI SYNDROME).

Heent

    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) KERATITIS
    a) A 61-year-old man was stung in the face by Physalia utriculus (blue bottle) while swimming. He developed immediate pain, facial swelling and bilateral blurred vision and was treated at the beach with a hot shower followed by cold compresses to the face. On arrival to the Emergency Department he had facial lesions consistent with blue bottle tentacles and bilateral blurred vision and tearing, which improved rapidly in the right eye and gradually improved in the left eye over a day. On slit lam exam he had pseudo-dendritiform lesions and crystalline deposits on the left cornea and conjunctival injection. The crystalline deposits were debrided on the 3rd day and by day 5 he was asymptomatic (Chui et al, 2011).

Cardiovascular

    3.5.2) CLINICAL EFFECTS
    A) HYPOTENSIVE EPISODE
    1) WITH POISONING/EXPOSURE
    a) Hypotension occurs with American coelenterate species (Bengston et al, 1991).
    B) HYPERTENSIVE EPISODE
    1) WITH POISONING/EXPOSURE
    a) Hypertension and tachycardia were reported, as part of an Irukandji-like syndrome, in 2 military combat diver students, who were stung by a jellyfish while in the water off of Key West, Florida. Vital signs of both patients returned to normal 3 hours post-envenomation (Grady & Burnett, 2003). Although the specific jellyfish responsible was not identified, it is suggested that a member of the Carybdeid species may have been the causative organism.
    C) TACHYCARDIA
    1) WITH POISONING/EXPOSURE
    a) Tachycardia was reported in a small number of patients with jellyfish stings in Brazil. Patients with systemic effects had larger stings, with long, linear, crossed marks of more than 20 cm on the skin (Haddad et al, 2010).
    b) Tachycardia and hypertension were reported, as part of an Irukandji-like syndrome, in 2 military combat diver students, who were stung by a jellyfish while in the waters off of Key West, Florida. Both patients vital signs returned to normal 3 hours post-envenomation (Grady & Burnett, 2003). Although the specific jellyfish responsible was not identified, it is suggested that a member of the Carybdeid species may have been the causative organism.
    D) CYANOSIS
    1) WITH POISONING/EXPOSURE
    a) CIRCULATION may be severely impaired by edema caused by jellyfish stings of the extremities. The impairment may cause absent pulses, regional cyanosis, and the threat of distal gangrene (Williamson et al, 1988).
    E) SUPERFICIAL THROMBOPHLEBITIS
    1) WITH POISONING/EXPOSURE
    a) Several cases of Mondor's disease (superficial thrombophlebitis of the breast) have been reported after jellyfish stings. This condition may appear as a cord-like, sometimes branched, palpable, swelling. An overlying cutaneous groove is often seen (Ingram et al, 1992).

Respiratory

    3.6.2) CLINICAL EFFECTS
    A) DYSPNEA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 20-year-old woman presented to the ED with Irukandji-like syndrome, consisting of limb cramping, backache, headache, agitation, hypertension, vomiting, dyspnea, pleuritic chest pain, and welts on her calves, with signs and symptoms occurring less than 2 hours after swimming in the southern waters of Australia. With supportive care, the patient's signs and symptoms completely resolved within 24 hours with no sequelae. It was suggested that the patient's signs and symptoms were a result of a jellyfish envenomation, possibly a non-Carukia jellyfish because of the development of a milder set of signs and symptoms, although the patient did not recall sighting a jellyfish while swimming (Cheng et al, 1999).
    b) Two military combat diver students were stung by a jellyfish while in the water off of Key West, Florida, and 30 minutes later developed an Irukandji-like syndrome, consisting of muscular rigidity, headache, back pain, abdominal cramping, nausea, vomiting, lacrimation, salivation, cough, dyspnea, anxiety, and agitation. Symptoms increased in intensity over the next 2 hours post-envenomation and then gradually decreased over the following 4 hours with supportive care (Grady & Burnett, 2003). Although the specific jellyfish responsible was not identified, it is suggested that a member of the Carybdeid species may have been the causative organism.
    c) In a series of 280 jellyfish stings reported to Texas poison control centers from 2000 to 2004, 2 patients reported dyspnea (Forrester, 2006).
    d) Dyspnea was reported in a small number of patients with jellyfish stings in Brazil. Patients with systemic effects had larger stings, with long, linear, crossed marks of more than 20 cm on the skin (Haddad et al, 2010).

Neurologic

    3.7.2) CLINICAL EFFECTS
    A) NEUROTOXICITY
    1) WITH POISONING/EXPOSURE
    a) In a series of 280 jellyfish stings reported to Texas poison control centers from 2000 to 2004, neurologic effects were reported in 5 patients (2%). This included: confusion (1), dizziness (1), drowsiness (1), headache (2), muscle weakness (1), numbness (1), and tremor (1) (Forrester, 2006).
    B) COMA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A healthy, 67-year-old, 205 pound swimmer was stung by 7 meters of tentacles of Physalia physalis (Portuguese man-of-war). The woman lapsed into an irreversible 5-day coma within 5 minutes of the sting. The death was thought to be due to cardiopulmonary effects of the venom, not allergy (Stein et al, 1989).
    C) PARALYSIS
    1) WITH POISONING/EXPOSURE
    a) Paresis of finger, hand, and forearms has developed after swelling due to jellyfish stings of the arms and upper body (Williamson et al, 1988) (Hach-Wunderle, 1987) (Kaufman, 1992).
    D) NEURITIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Mononeuritis, consisting of pain, muscular weakness, and paresthesias of the extremities, was reported following jellyfish stings. Spontaneous recovery occurred over a period of several months (Burnett et al, 1994).
    E) HEADACHE
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 20-year-old woman presented to the ED with Irukandji-like syndrome, consisting of limb cramping, backache, headache, agitation, hypertension, vomiting, dyspnea, pleuritic chest pain, and welts on her calves, with signs and symptoms occurring less than 2 hours after swimming in the southern waters of Australia. With supportive care, the patient's signs and symptoms completely resolved within 24 hours with no sequelae. It was suggested that the patient's signs and symptoms were a result of a jellyfish envenomation, possibly a non-Carukia jellyfish because of the development of a milder set of signs and symptoms, although the patient did not recall sighting a jellyfish while swimming (Cheng et al, 1999).
    b) Two military combat diver students were stung by a jellyfish while in the water off of Key West, Florida, and 30 minutes later developed an Irukandji-like syndrome, consisting of muscular rigidity, headache, back pain, abdominal cramping, nausea, vomiting, lacrimation, salivation, cough, dyspnea, anxiety, and agitation. Symptoms increased in intensity over the next 2 hours post-envenomation and then gradually decreased over the following 4 hours with supportive care (Grady & Burnett, 2003). Although the specific jellyfish responsible was not identified, it is suggested that a member of the Carybdeid species may have been the causative organism.

Gastrointestinal

    3.8.2) CLINICAL EFFECTS
    A) NAUSEA AND VOMITING
    1) WITH POISONING/EXPOSURE
    a) Two military combat diver students were stung by a jellyfish while in the waters off of Key West, Florida, and 30 minutes later developed an Irukandji-like syndrome, consisting of muscular rigidity, headache, back pain, abdominal cramping, nausea, vomiting, lacrimation, salivation, cough, dyspnea, anxiety and agitation. Symptoms increased in intensity over the next 2 hours post-envenomation and then gradually decreased over the following 4 hours with supportive care (Grady & Burnett, 2003). Although the specific jellyfish responsible was not identified, it is suggested that a member of the Carybdeid species may have been the causative organism.
    b) In a series of 280 jellyfish stings reported to Texas poison control centers from 2000 to 2004, GI effects were reported in 11 patients (4%). This included: nausea (4), vomiting (4), abdominal pain (3), diarrhea (1), oral irritation (1), and throat irritation (1) (Forrester, 2006).
    c) Vomiting was reported in a small number of patients with jellyfish stings in Brazil. Patients with systemic effects had larger stings, with long, linear, crossed marks of more than 20 cm on the skin (Haddad et al, 2010).
    B) ABDOMINAL PAIN
    1) WITH POISONING/EXPOSURE
    a) Cramping was noted after jellyfish ingestion and envenomation (Little & Mulcahy, 1998; Burnett & Calton, 1987).
    b) Two military combat diver students were stung by a jellyfish while in the water off of Key West, Florida, and 30 minutes later developed an Irukandji-like syndrome, consisting of muscular rigidity, headache, back pain, abdominal cramping, nausea, vomiting, lacrimation, salivation, cough, dyspnea, anxiety, and agitation. Symptoms increased in intensity over the next 2 hours post-envenomation and then gradually decreased over the following 4 hours with supportive care (Grady & Burnett, 2003). Although the specific jellyfish responsible was not identified, it is suggested that a member of the Carybdeid species may have been the causative organism.
    C) PARALYTIC ILEUS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 31-year-old man was stung by a jellyfish and, within 30 minutes, developed urticarial lesions on the left forearm at the site of the envenomation, generalized malaise, weakness, lethargy, joint pains, and abdominal bloating. Abdominal distension with absent bowel sounds and vomiting were noted on presentation to the ED 24 hours after the envenomation and a clinical diagnosis of paralytic ileus was made. With supportive care, the patient recovered 4 days later (Ponampalam, 2002).

Genitourinary

    3.10.2) CLINICAL EFFECTS
    A) ACUTE RENAL FAILURE SYNDROME
    1) WITH POISONING/EXPOSURE
    a) A 4.5 year-old girl was stung by a Portuguese man-of-war. She rapidly developed painful red vesicular lesions in the pattern of tentacles over about 10% of her body surface area. She was initially treated with dexamethasone, epinephrine and diphenhydramine and was discharged. She continued to have severe pain, progressive swelling of the involved extremities and no urine output for 10 hours. On reevaluation she had 40 mL of burgundy colored urine on catheterization that dipped positive for blood but had no red cells on microscopy. Her serum was grossly red, hematocrit was 28.9%, total and conjugated bilirubin were 5.1 and 3.7 mg/100 ml, respectively. Serum creatinine was 1.8 mg/dL, BUN 50 mg/dL and potassium was 6.9 mEq/L. She received red blood cell transfusion, oliguria persisted so she was transferred. About 24 hours after the sting she was icteric with persistent oliguria, edema and sting lesions were present on the left arm and both legs and pulses were reduced in the left arm. Lactic dehydrogenase (LDH) was 7,371 unit/L, SGOT 455 units/L, creatine phosphokinase (CPK) 554 units/L, total bilirubin was 7.4 mg/dL, creatinine concentration was 3.0 and BUN 82 mg/dL. Measurements of serum-free hemoglobin, obtained 48 and 96 hours after the sting, were 12.3/dL and 11.0 mg/dL, respectively. Hematocrit values did not change after the initial transfusion. She remained oliguric despite intravenous fluids and furosemide. She required 5 sessions of hemodialysis. Oliguria resolved 10 days after the sting and urine volumes returned to normal over the following 10 days (Guess et al, 1982; Spielman et al, 1982).

Hematologic

    3.13.2) CLINICAL EFFECTS
    A) HEMOLYSIS
    1) WITH POISONING/EXPOSURE
    a) A 4.5 year-old girl was stung by a Portuguese man-of-war. She rapidly developed painful red vesicular lesions in the pattern of tentacles over about 10% of her body surface area. She was initially treated with dexamethasone, epinephrine and diphenhydramine and was discharged. She continued to have severe pain, progressive swelling of the involved extremities and no urine output for 10 hours. On reevaluation she had 40 mL of burgundy colored urine on catheterization that dipped positive for blood but had no red cells on microscopy. Her serum was grossly red, hematocrit was 28.9%, total and conjugated bilirubin were 5.1 and 3.7 mg/100 mL, respectively. Serum creatinine was 1.8 mg/dL, BUN 50 mg/dL and potassium was 6.9 mEq/L. She received red blood cell transfusion, oliguria persisted so she was transferred. About 24 hours after the sting she was icteric with persistent oliguria, edema and sting lesions were present on the left arm and both legs and pulses were reduced in the left arm. Lactic dehydrogenase (LDH) was 7,371 units/L, SGOT 455 units/L, creatine phosphokinase (CPK) 554 units/L, total bilirubin was 7.4 mg/dL, creatinine concentration was 3.0 and BUN 82 mg/dL. Measurements of serum-free hemoglobin, obtained 48 and 96 hours after the sting, were 12.3 mg/dL and 11.0 mg/dL, respectively. Hematocrit values did not change after the initial transfusion. She remained oliguric despite intravenous fluids and furosemide. She required 5 sessions of hemodialysis. Oliguria resolved 10 days after the sting and urine volumes returned to normal over the following 10 days (Guess et al, 1982; Spielman et al, 1982).

Dermatologic

    3.14.2) CLINICAL EFFECTS
    A) SKIN FINDING
    1) WITH POISONING/EXPOSURE
    a) Acute local effects may include pain, skin eruption, exaggerated local angioedema, and papular urticaria (Fisher, 1999; Burnett, 1991).
    b) In a series of 280 jellyfish stings reported to Texas poison control centers from 2000 to 2004, dermal irritation or pain was reported in 244 (80%), erythema in 95 (34%), puncture wounds in 67 (24%), welts in 48 (17%), and edema in 40 (14). Other less common effects were rash (13), pruritus (12), cellulitis (2), and ecchymosis (1) (Forrester, 2006).
    B) JELLYFISH STING
    1) WITH POISONING/EXPOSURE
    a) LESIONS: The cutaneous lesions produced by the nematocyst vary considerably, depending chiefly on the organism involved (Letot et al, 1990).
    b) The lesions may appear as small papular eruptions in one or several discontinuous lines, particularly when tentacles are involved, or they may appear as a cluster of small wheals, or papules, often surrounded by a reddened, raised area (as in sea anemone stings).
    c) The papules may increase in size and proceed to vesication within the first 24 hours (Russell & Tomchik, 1993). Pustules may develop and desquamation is not unusual in more severe cases.
    d) Contact with an organism may produce a sharp, shooting pain, or initial pain may be absent. The presenting findings may often show as pruritus and lymphadenopathy.
    e) Some stings may result in skin necrosis (Othman et al, 1991).
    f) ERYTHEMA NODOSUM with articular manifestations was noted after stings by an unidentified jellyfish (Auerbach & Hays, 1987).
    g) There may be both an immediately "toxic" cutaneous reaction, then some days later an allergic reaction (Fisher, 1987).
    h) A case of generalized skin eruption was seen after ingestion of jellyfish (Marr, 1967).
    C) PILOERECTION
    1) WITH POISONING/EXPOSURE
    a) Piloerection has been seen following stings by many venomous animals, including the coelenterates.
    D) DISCOLORATION OF SKIN
    1) WITH POISONING/EXPOSURE
    a) Hyperpigmentation is an usual reaction sometimes seen after jellyfish envenomations by Pelagia noctiluca. It may result from post inflammatory melanin deposition or tattooing of the mauve jellyfish pigment into the skin (Kokelj & Burnett, 1990).
    E) PAIN
    1) WITH POISONING/EXPOSURE
    a) Initial dermal contact with a non-chirodropid coelenterate may result in localized pain that may radiate to other areas of the body. The severity of pain may range from mild stinging to a severe burning sensation (Fisher, 1999; Kaufman, 1992).
    b) In a series of 280 jellyfish stings reported to Texas poison control centers from 2000 to 2004, dermal irritation or pain was reported in 244 (80%) (Forrester, 2006).
    F) BULLOUS ERUPTION
    1) WITH POISONING/EXPOSURE
    a) SEABATHER'S ERUPTION: An usually self-limiting illness that has been associated with the larvae of the jellyfish Linuche unguiculator. These larvae are known as "sea lice" (Tomchik et al, 1993).
    b) The condition is an intensely pruritic, vesicular, maculopapular eruption seen around the swimwear of bathers. Onset: Within 24 hours. Duration: 3 to 5 days (Sams, 1949; Strauss, 1956; Moschella, 1951).
    c) Systemic symptoms include fever, nausea, vomiting, diarrhea, headache, chills, weakness, malaise, muscle spasms, and arthralgias. It is unknown if these symptoms are an immune response or reaction caused by ingestion of infested water (Russell & Tomchik, 1993).
    d) Treatment is symptomatic with use of antihistamines, antipruritics, and corticosteroids. This condition has been reported around various Florida beaches (Tomchik et al, 1993).
    G) NECROSIS
    1) WITH POISONING/EXPOSURE
    a) A 35-year-old woman with diabetes was stung by what was believed to be a Portuguese man-of-war on the dorsum of the foot. The wound was initially incised and a drain was placed. The foot remained red and swollen and she was admitted again for IV antibiotics. About a month after the initial injury her foot became cool and dusky. She was admitted with non-viable skin that was debrided; antibiotics were started. Cultures grew coagulase negative staphylococci and tissue microscopy showed epidermal necrosis. She was readmitted 6 weeks later for further debridement and split thickness skin grafting and recovered (Giordano et al, 2005).
    H) ITCHING OF SKIN
    1) WITH POISONING/EXPOSURE
    a) An adult developed erythematous, intensely pruritic papular lesions that progressed to urticarial lesions after contact with the hydrozoa Nemalecium lighti while snorkeling. The lesions improved with oral and topical antihistamines (Haddad et al, 2010).

Musculoskeletal

    3.15.2) CLINICAL EFFECTS
    A) MUSCLE PAIN
    1) WITH POISONING/EXPOSURE
    a) Muscle pain and cramps have been reported 5 to 10 minutes after stings by several species (Mulcahy & Little, 1997; Kaufman, 1992).
    b) CASE REPORT: A 20-year-old woman presented to the ED with Irukandji-like syndrome, consisting of limb cramping, backache, headache, agitation, hypertension, vomiting, dyspnea, pleuritic chest pain, and welts on her calves, with signs and symptoms occurring less than 2 hours after swimming in the southern waters of Australia. With supportive care, the patient's signs and symptoms completely resolved within 24 hours with no sequelae. It was suggested that the patient's signs and symptoms were a result of a jellyfish envenomation, possibly a non-Carukia jellyfish because of the development of a milder set of signs and symptoms, although the patient did not recall sighting a jellyfish while swimming (Cheng et al, 1999).
    c) Three military combat diver students experienced severe back pain and muscle cramping, as part of an Irukandji-like syndrome, within 25 minutes after being stung by a jellyfish while in the water off of Key West Florida. The symptoms increased in intensity over the next 2 hours following envenomation and then gradually decreased over the following 4 hours (Grady & Burnett, 2003). Although the specific jellyfish responsible was not identified, it is suggested that a member of the Carybdeid species may have been the causative organism.
    B) COMPARTMENT SYNDROME
    1) WITH POISONING/EXPOSURE
    a) Muscle necrosis, compartment syndrome and arterial spasm have been reported after severe stings (Williamson et al, 1988).
    C) ARTHRITIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 74-year-old man was stung by a Portuguese man-of-war while swimming. Redness and edema over the site of the sting lasted 3 days. About a week after the sting he developed swelling of the dorsum of both hands, and wrist pain. Erythrocyte sedimentation rate was elevated but other laboratory studies were normal. He was treated with wrist splints and NSAIDs but symptoms finally resolved after low dose corticosteroid treatment (Weinberg, 1988).

Immunologic

    3.19.2) CLINICAL EFFECTS
    A) ANAPHYLACTOID REACTION
    1) WITH POISONING/EXPOSURE
    a) Anaphylaxis occurs rarely due to jellyfish stings (Burnett, 1991; Laing & Harrison, 1991). However, true anaphylactic reactions following jellyfish stings are becoming more common.
    B) INCREASED IMMUNOGLOBULIN
    1) WITH POISONING/EXPOSURE
    a) Jellyfish stings will normally elevate serum levels of IgG and IgM. Elevated levels may persist for up to 4 years after a sting (Burnett, 1991; Auerbach & Hays, 1987).

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) Monitor vital signs following jellyfish envenomations.
    B) ECG and continuous cardiac monitoring should be performed in patients with signs and symptoms of cardiac dysfunction.

Radiographic Studies

    A) CHEST RADIOGRAPH
    1) Obtain a chest x-ray in symptomatic patients.

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.6) DISPOSITION/BITE-STING EXPOSURE
    6.3.6.1) ADMISSION CRITERIA/BITE-STING
    A) Patients with intractable pain or severe systemic manifestations should be admitted.
    6.3.6.2) HOME CRITERIA/BITE-STING
    A) Most patients can be managed at home with dermal decontamination, and home or over-the-counter treatments for pain and pruritus.
    6.3.6.3) CONSULT CRITERIA/BITE-STING
    A) Consult a medical toxicologist or poison center for patients with severe symptoms or in whom the diagnosis is unclear.
    6.3.6.5) OBSERVATION CRITERIA/BITE-STING
    A) Patients with severe pain or systemic manifestations should be referred to a healthcare facility.

Monitoring

    A) Monitor vital signs following jellyfish envenomations.
    B) ECG and continuous cardiac monitoring should be performed in patients with signs and symptoms of cardiac dysfunction.

Case Reports

    A) SPECIFIC AGENT
    1) AURELIA AURITA/MOON JELLYFISH: This species generally does not cause pain and swelling, but a 30-year-old swimming off the coast of Mississippi was stung under the arm and left knee and experienced symptoms.
    a) There was immediate severe pain and piloerection without sweating. Within a few minutes urticaria developed, then ulceration. The lesions were encrusted 3 to 9 days later. Hyperpigmentation was visible 2 weeks post envenomation. Pain persisted for only about 30 minutes.
    2) CARYBDEA MARSUPIALIS: An adult with a sting on the arm developed a burning sensation over 30 to 40 minutes. Within 10 minutes erythema and edema was seen, which increased over 4 hours. Lesions were healed within 3 days (Kokelj et al, 1992).

Summary

    A) TOXICITY: Fatalities are not well documented and if they do occur they are extremely rare.

Minimum Lethal Exposure

    A) CASE REPORT: A healthy 30-year-old man was scuba diving off the North Carolina, USA shore. He had ascended to 10 feet when he suddenly became rigid, seemed to panic and looked as if something had happened to his right arm. He dropped his weight belt, rapidly ascended, and was flopping about 100 ft from the nearest boat. Rescuers reached him 2 to 3 minutes later and he was pulseless and apneic. Observers saw a bluish purple jellyfish with a float (consistent with Portuguese Man-O'War) , and numerous tentacles were stuck to the man's skin and wet suit. He was brought to the boat, where CPR was administered, tentacles were removed and he was doused with vinegar. He was evacuated by helicopter to a hospital but could not be resuscitated (Burnett & Gable, 1989).

Toxicologic Mechanism

    A) JELLYFISH
    1) These venoms are mixtures of both toxic and antigenic polypeptides, and enzymes.
    2) The venom is released from a venom-coated tubule on the tentacle called a nematocyst, which injects a thread into the skin at 2 to 5 pounds of pressure per square inch. This is sufficient to penetrate the upper dermis, where the venom is released (Fenner & Williamson, 1996; Neeman et al, 1981).
    3) PHYSALIA PHYSALIS VENOM - contains DNase, elastases, histamine, and a collagenase (Werb et al, 1982; Lal et al, 1981; Cormier & Hessinger, 1981). Causes prostaglandin-induced vasodilatation (Hessinger DA, 1986).
    4) CHRYSAORA QUINQUECIRRHA VENOM - contains an acid protease (Burnett & Calton, 1987), and a hemagglutinin specific for human and rabbit red blood cells (Cobbs et al, 1983).
    a) An alkaline protease, a DNase, and a collagenase was also noted (Neeman et al, 1981; Lal et al, 1981a; Burnett & Calton, 1987). This sea nettle's venom depolarizes both muscles and nerves (Burnett & Calton, 1987).
    5) Children may be more vulnerable to death following jellyfish envenomations because they have relatively smaller body mass resulting in a higher concentration of venom in their tissues and organs, they may remain in the water and attempt to pull at the adherent tentacles which may cause further envenomation, and they have less body hair which allows for closer tentacle contact (Fenner & Williamson, 1996).
    B) NEMATOCYST INACTIVATION - Vinegar is known to inactive nematocysts, but the reaction is not due solely to acidity. Some mineral and organic acids produce nematocyst discharge; some weak acids do not (Rifkin et al, 1993).
    C) Vinegar may precipitate nematocyst firing in Chrysaora quinquecirrha (American sea nettle), Pelagia noctiluca (little mauve stinger jellyfish) and Cyanea captillata (hair or "lion's mane" jellyfish). Freshwater or alcohol may discharge nematocysts and should be avoided (Weisman, 2002).

General Bibliography

    1) Armoni M, Ohali M, Hay E, et al: Severe dyspnea due to jellyfish envenomation. Ped Emerg Care 2003; 19:84-86.
    2) Auerbach PS & Hays JT: Erythema nodosum following a jellyfish sting. J Emerg Med 1987; 5:487-491.
    3) Beadnell CE, Rider TA, & Williamson JA: Management of a major box jellyfish (Chironex fleckeri) sting: lessons from the first minutes and hours. Med J Aust 1992; 156:655-658.
    4) Bengston K, Nichols MM, & Schnadig V: Sudden death in a child following jellyfish envenomation by Chiropsalmus quadrumanus: case report and autopsy findings. JAMA 1991; 266:1404-1406.
    5) Benmeir P, Rosenberg L, & Sagi A: Jellyfish envenomation: a summer epidemic. Burns 1990; 16:471-472.
    6) Birsa LM, Verity PG, & Lee RF: Evaluation of the effects of various chemicals on discharge of and pain caused by jellyfish nematocysts. Comp Biochem Physiol C Toxicol Pharmacol 2010; 151(4):426-430.
    7) Boulware DR: A randomized, controlled field trial for the prevention of jellyfish stings with a topical sting inhibitor. J Travel Med 2006; 13(3):166-171.
    8) Burnett JW & Calton GJ: Jellyfish envenomation syndromes updated. Ann Emerg Med 1987; 16:1000-1005.
    9) Burnett JW & Gable WD: A fatal jellyfish envenomation by the Portuguese man o'war. Toxicon 1989; 27:823-824.
    10) Burnett JW, Williamson JA, & Fenner PJ: Mononeuritis multiplex after coelenterate sting. Med J Aust 1994; 161:320-322.
    11) Burnett JW: Immunologic aspects of jellyfish envenomation (abstract 118), 10th World Congress on Animal, Plant, and Microbial Toxins, Singapore, China, 1991.
    12) Cheng AC, Winkel KD, Hawdon GM, et al: Irukandji-like syndrome in Victoria. Aust NZ J Med 1999; 29:835.
    13) Chui JJ, Ooi KG, Reeves D, et al: Bluebottle envenomation-induced crystalline keratopathy. Cornea 2011; 30(7):835-837.
    14) Cobbs CS, Gold P, & Calton GJ: Sea nettle (Chrysaora quinquecirrha) nematocyst venom hemagglutinins. Comp Biochem Physiol 1983; 74C:225.
    15) Cormier SM & Hessinger DA: Physalia venom mediates histamine release from mast cells. J Exp Zool 1981; 218:117.
    16) Currie B, Khanh DM, & Alderslade P: Jellyfish envenomation in the northern territory of Australia (abstract 204), 10th World Congress on Animal, Plant, and Microbial Toxins, Singapore, China, 1991.
    17) Exton DR, Fenner PJ, & Williamson JA: Cold packs: effective topical analgesia in the treatment of painful stings by Physalia and other jellyfish. Med J Aust 1989; 151:625-626.
    18) Exton DR: Treatment of Physalia physalis envenomation. Med J Aust 1988; 149(1):54-54.
    19) Fenner P: Marine envenomation (letter - reply). Emerg Med 2001; 13:392-394.
    20) Fenner PJ & Williamson JA: Worldwide deaths and severe envenomation from jellyfish stings. Med J Aust 1996; 165:658-661.
    21) Fenner PJ, Williamson J, & Callanan I: Further understanding of, and a new treatment for "Irukandji" (Carukia barnesi) stings. Med J Aust 1986; 145:569-574.
    22) Fisher AA: Aquatic dermatitis, part I. Dermatitis caused by coelenterates. Cutis 1999; 64:84-86.
    23) Fisher AA: Toxic and allergic cutaneous reactions to jellyfish with special reference to delayed reactions. Cutis 1987; 40:303-305.
    24) Forrester MB: Epidemiology of jellyfish stings reported to poison centers in Texas. Hum Exp Toxicol 2006; 25(4):183-186.
    25) Giordano AR, Vito L, & Sardella PJ: Complication of a Portuguese man-of-war envenomation to the foot: a case report. J Foot Ankle Surg 2005; 44(4):297-300.
    26) Grady JD & Burnett JW: Irukandji-like syndrome in South Florida divers. Ann Emerg Med 2003; 42:763-766.
    27) Guess HA, Saviteer PL, & Morris CR: Hemolysis and acute renal failure following a Portuguese man-of-war sting. Pediatrics 1982; 70(6):979-981.
    28) Haddad V Jr, Silveira FL, & Migotto AE: Skin lesions in envenoming by cnidarians (Portuguese man-of-war and jellyfish): etiology and severity of accidents on the Brazilian coast. Rev Inst Med Trop Sao Paulo 2010; 52(1):47-50.
    29) Hessinger DA: Biochemistry and action of a hydrozoan and anthozoan venom. Loma Linda Conference on Nematocysts (May), 1986.
    30) Ingram DM, Sheiner HJ, & Ginsberg AM: Mondor's disease of the breast resulting from jellyfish sting. Med J Aust 1992; 157:836-837.
    31) Kaufman MB: Portuguese man-of war envenomation. Ped Emerg Care 1992; 8:27-28.
    32) Kimball AB, Arambula KZ, Stauffer AR, et al: Efficacy of a jellyfish sting inhibitor in preventing jellyfish stings in normal volunteers. Wilderness Environ Med 2004; 15:102-108.
    33) Kleinman ME, Chameides L, Schexnayder SM, et al: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 14: pediatric advanced life support. Circulation 2010; 122(18 Suppl.3):S876-S908.
    34) Kokelj F & Burnett JW: Treatment of a pigmented lesion induced by a Pelagia noctilca sting. Cutis 1990; 46:62-63.
    35) Kokelj F, Del Negro P, & Montanari G: Jellyfish dermatitis due to Carybdea marsupialis. Contact Dermatitis 1992; 27:195.
    36) Laing JHE & Harrison DH: Envenomation by the box-jellyfish - an unusual cause of ulnar nerve palsy. J Roy Soc Med 1991; 84:115-116.
    37) Lal DM, Calton GJ, & Burnett JW: Characterization of Chrysaora quinquecirrha (sea nettle) nematocyst venom collagenase. Comp Biochem Physiol 1981a; 69B:529.
    38) Lal DM, Calton GJ, & Neeman I: Characterization of Physalia physalis (Portuguese man-o'war) nematocyst collagenase. Comp Biochem Physiol 1981; 70B:635.
    39) Letot B, Pierard-Franchimont C, & Pierard GE: Acute reactions to coelenterates. Dermatologica 1990; 180:224-227.
    40) Lieberman P, Nicklas R, Randolph C, et al: Anaphylaxis-a practice parameter update 2015. Ann Allergy Asthma Immunol 2015; 115(5):341-384.
    41) Lieberman P, Nicklas RA, Oppenheimer J, et al: The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010; 126(3):477-480.
    42) Little M & Mulcahy RF: A year's experience of Irukandji envenomation in far north Queensland. Med J Aust 1998; 169:638-641.
    43) Little M, Mulcahy RF, & Wenck DJ: Life-threatening cardiac failure in a healthy young female with irukandji syndrome. Anaesth Intens Care 2001; 29:178-180.
    44) Lopez EA, Weisman RS, & Bernstein J: A prospective study of the acute therapy of jellyfish envenomations (abstract). J Toxicol Clin Toxicol 2000; 38:513.
    45) Loten C, Stokes B, Worsley D, et al: A randomised controlled trial of hot water (45 degrees C) immersion versus ice packs for pain relief in bluebottle stings. Med J Aust 2006; 184(7):329-333.
    46) Marr JF: Protuguese man-of-war envenomization: a personal experience. JAMA 1967; 199:155.
    47) Martin JC & Audley I: Cardiac failure following Irukandji envenomation. Med J Aust 1990; 153:164-166.
    48) Mebs: Cnidarians (phylum: Cnidaria) In: Mebs D: Venomous and Poisonous Animals: A Handbook for Biologists, Toxicologists and Toxinologists, Physicians and Pharmacists, CRC Press, Boca Raton, FL, 2002, pp 39-66.
    49) Moschella SL: Further clinical observations on seabather's eruption. Arch Dermatol 1951; 64:55-56.
    50) Mulcahy R & Little M: Thirty cases of irukandji envenomation from far north Queensland. Emerg Med 1997; 9:297-299.
    51) National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    52) Neeman I, Calton GJ, & Burnett JW: Purificationof an endonuclease present in the Chrysaora quinquecirrha venom. Proc Soc Exp Biol Med 1981; 166:374.
    53) Nomura JT, Sato RL, Ahern RM, et al: A randomized paired comparison trial of cutaneous treatments for acute jellyfish (Carybdea alata) stings. Am J Emerg Med 2002; 20:624-626.
    54) Nowak RM & Macias CG : Anaphylaxis on the other front line: perspectives from the emergency department. Am J Med 2014; 127(1 Suppl):S34-S44.
    55) Othman I, Mustaffa MR, & Sulaiman S: Effect of Chrysaora hyoscella on longitudinal muscle of the guinea pig ileum (abstract 231), 10th World Congress on Animal, Plant, and Microbial Toxins, Singapore, China, 1991.
    56) Peberdy MA , Callaway CW , Neumar RW , et al: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care science. Part 9: post–cardiac arrest care. Circulation 2010; 122(18 Suppl 3):S768-S786.
    57) Ponampalam R: An unusual case of paralytic ileus after jellyfish envenomation. Emerg Med J 2002; 19:357-358.
    58) Product Information: diphenhydramine HCl intravenous injection solution, intramuscular injection solution, diphenhydramine HCl intravenous injection solution, intramuscular injection solution. Hospira, Inc. (per DailyMed), Lake Forest, IL, 2013.
    59) Product Information: dopamine hcl, 5% dextrose IV injection, dopamine hcl, 5% dextrose IV injection. Hospira,Inc, Lake Forest, IL, 2004.
    60) Product Information: norepinephrine bitartrate injection, norepinephrine bitartrate injection. Sicor Pharmaceuticals,Inc, Irvine, CA, 2005.
    61) Rifkin J, Williamson J, & Fenner P: Disarming the box-jellyfish. Med J Aust 1993; 158:647-648.
    62) Russell MT & Tomchik RS: Clinical articles Seabather's eruption, or "sea lice": new findings and clinical implications. J Emerg Nurs 1993; 19:197-201.
    63) Sams WM: Seabather's eruption. Arch Dermatol 1949; 60:227-237.
    64) Spielman FJ, Bowe EA, Watson CB, et al: Acute renal failure as a result of Physalia physalis sting. South Med J 1982; 75(11):1425-1426.
    65) Stein MR, Marraccini JV, & Rothschild NE: Fatal Portuguese man o'war (Physalia physalis) envenomation. Ann Emerg Med 1989; 18:312-315.
    66) Strauss JS: Seabather's eruption. Arch Dermatol 1956; 74:293-295.
    67) Taylor JG: Treatment of jellyfish stings. Med J Aust 2007; 186(1):43-.
    68) Thomas CS, Scott SA, Galanis DJ, et al: Box jellyfish (Carybdea alata) in Waikiki. The analgesic effect of Sting-Aid, Adolph's meat tenderizer and fresh water on their stings: a double-blinded, randomized, placebo-controlled clinical trial. Hawaii Med J 2001; 60:205-210.
    69) Tomchik RS, Russell MR, & Szmant AM: Clinical perspectives on seabather's eruption, also known as "sea lice. JAMA 1993; 269:1669-1672.
    70) Tonseth KA, Andersen TS, Pripp AH, et al: Prophylactic treatment of jellyfish stings--a randomised trial. Tidsskr Nor Laegeforen 2012; 132(12-13):1446-1449.
    71) Vanden Hoek,TL; Morrison LJ; Shuster M; et al: Part 12: Cardiac Arrest in Special Situations 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. American Heart Association. Dallas, TX. 2010. Available from URL: http://circ.ahajournals.org/cgi/reprint/122/18_suppl_3/S829. As accessed 2010-10-21.
    72) Ward NT, Darracq MA, Tomaszewski C, et al: Evidence-based treatment of jellyfish stings in North America and Hawaii. Ann Emerg Med 2012; 60(4):399-414.
    73) Weinberg SR: Reactive arthritis following a sting by a Portuguese man-of-war. J Fla Med Assoc 1988; 75(5):280-281.
    74) Weisman RS: Marine Envenomations In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al (Eds): Goldfrank's Toxicologic Emergencies, 7. McGraw-Hill, New York, NY, 2002a.
    75) Weisman RS: Marine Envenomations In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al (Eds): Goldrank's Toxicologic Emergencies, 7th. McGraw-Hill, 2002, pp 1592-1597.
    76) Werb Z, Banda MJ, & McCarrow JH: Elastases and elastin degradation. J Invest Derm 1982; 79:154S.
    77) Williamson J & Burnett J: Clinical toxicology of marine coelenterate injuries In: Meier J & White J (Eds): Handbook of Clinical Toxicology of Animal Venoms and Poisons, CRC, Boca Raton, FL, 1995, pp 91-107.
    78) Williamson JA, Burnett JW, & Fenner PJ: Acute regional vascular insufficiency after jellyfish envenomation. Med J Aust 1988; 149:698-701.
    79) Yoshimoto CM & Yanagihara AA: Cnidarian (coelenterate) envenomations in Hawai'i improve following heat application. Trans Royal Soc Trop Med Hyg 2002; 96:300-303.